Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis.

Literature DB >> 23828261

Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis.

T Barbui¹, A Carobbio, G Finazzi, P Guglielmelli, S Salmoiraghi, V Rosti, A Rambaldi, A M Vannucchi, G Barosi.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2013 PMID： 23828261 DOI： 10.1038/leu.2013.207

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

Keyword Cloud
Cited

× No keyword cloud information.

24 in total

Review 1. Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.

Authors: Giovanni Barosi
Journal: Curr Hematol Malig Rep Date: 2015-12 Impact factor: 3.952

2. Circulating immune/inflammation markers in Chinese workers occupationally exposed to formaldehyde.

Authors: Wei Jie Seow; Luoping Zhang; Roel Vermeulen; Xiaojiang Tang; Wei Hu; Bryan A Bassig; Zhiying Ji; Meredith S Shiels; Troy J Kemp; Min Shen; Chuangyi Qiu; Boris Reiss; Laura E Beane Freeman; Aaron Blair; Christopher Kim; Weihong Guo; Cuiju Wen; Laiyu Li; Ligia A Pinto; Hanlin Huang; Martyn T Smith; Allan Hildesheim; Nathaniel Rothman; Qing Lan
Journal: Carcinogenesis Date: 2015-04-23 Impact factor: 4.944

Review 3. Epidemiology of MPN: what do we know?

Authors: L A Anderson; M F McMullin
Journal: Curr Hematol Malig Rep Date: 2014-12 Impact factor: 3.952

Review 4. Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Authors: S Koschmieder; T I Mughal; H C Hasselbalch; G Barosi; P Valent; J-J Kiladjian; G Jeryczynski; H Gisslinger; J S Jutzi; H L Pahl; R Hehlmann; A Maria Vannucchi; F Cervantes; R T Silver; T Barbui
Journal: Leukemia Date: 2016-02-08 Impact factor: 11.528

Review 5. An immune dysregulation in MPN.

Authors: Giovanni Barosi
Journal: Curr Hematol Malig Rep Date: 2014-12 Impact factor: 3.952

Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis.

Review 1. Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.

2. Circulating immune/inflammation markers in Chinese workers occupationally exposed to formaldehyde.

Review 3. Epidemiology of MPN: what do we know?

Review 4. Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Review 5. An immune dysregulation in MPN.

Review 6. Leukemia secondary to myeloproliferative neoplasms.

7. Assessment of bone marrow inflammation in patients with myelofibrosis: an 18F-fluorodeoxyglucose PET/CT study.

Review 8. Allogeneic transplantation for myelofibrosis: for whom, when, and what are the true benefits?

Review 9. Accelerated Phase of Myeloproliferative Neoplasms.

Review 10. Overview of Myeloproliferative Neoplasms: History, Pathogenesis, Diagnostic Criteria, and Complications.